In contrast, silencing FOXM1 by shRNAs dramatically attenuated the tumor-promoting effects of MELK on ESCC cells; (3) Overexpression or knockdown of FOXM1 hardly changed the protein levels of MELK. The gene discussed is FOXM1; the disease is esophageal squamous cell carcinoma.